Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097396
Status:
COMPLETED
Last Update Posted:
2011-06-30
First Post:
2004-11-23
Brief Title:
Safety Tolerability Immunogenicity of the Recombinant Plague Vaccine rF1V
Sponsor:
DynPort Vaccine Company LLC A GDIT Company
Organization:
DynPort Vaccine Company LLC A GDIT Company
Organization Data
Organization:
DynPort Vaccine Company LLC A GDIT Company
Class:
INDUSTRY
Study ID:
rF1V-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
DynPort Vaccine Company LLC A GDIT Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Chief Medical Officer
Old Organization:
DynPort Vaccine Company LLC